InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,172.80
(
0.55%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.37%
)
Bitcoin
65,866.83
(
-1.32%
)
Post# of 252181
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 154152

Friday, 01/18/2013 11:09:21 PM

Friday, January 18, 2013 11:09:21 PM

Post# of 252181

ELN sets exchange ratio for Prothena drug-discovery spinoff—1 share of Prothena for each 41 shares of ELN:

finance.yahoo.com/news/elan-announces-expected-timetable-respect-214500696.html

Prothena shares will trade on Nasdaq under the symbol PRTA starting 12/21/12; Prothena when issued shares (PRTA.WI) will trade from 12/18/12 through the close on 12/20/12.

Does anyone here care?

So, about a $150M market cap for Prothena based on the conversion ratio? You think that presents a reasonable risk-reward for the company? Here's the Web site and pipeline: http://www.prothena.com/03_Programs/Programs.html .
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up